Medincell
Medincell is a clinical- and commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs. Their innovative treatments aim to improve medicine effectiveness and accessibility while reducing environmental impact, using their proprietary BEPO® technology. The company collaborates with pharmaceutical companies and foundations to improve global health.
Funding Round: Grant
Funding Amount: $6M
Date: 08-Apr-2024
Investors: Unitaid
Markets: Biopharmaceutical, Pharmaceuticals, Drug Discovery, Biotechnology
HQ: Jacou, Occitanie, France
Founded: 2002
Website: https://www.medincell.com
LinkedIn: https://www.linkedin.com/company/medincell/
Twitter: https://twitter.com/medincell
Crunchbase: https://www.crunchbase.com/organization/medincell
Leave a Comment
Comments
No comments yet.